Alberto Dominguez-Rodriguez1, Pedro Abreu-Gonzalez2, Alejandro Jimenez-Sosa3, Julia Gonzalez4, Natalia Caballero-Estevez4, Felisa Vanesa Martín-Casañas4, Antonio Lara-Padron4, Juan M Aranda5. 1. Department of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, Tenerife E-38320, Spain adrvdg@hotmail.com. 2. Department of Physiology, University of La Laguna, Tenerife, Spain. 3. Research Unit, Hospital Universitario de Canarias, Tenerife, Spain. 4. Department of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, Tenerife E-38320, Spain. 5. Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
Abstract
AIMS: Frailty status impacts the prognosis in older patients with heart disease. However, frailty status impact is unknown in patients with non-ischaemic cardiomyopathy after cardiac resynchronization therapy (CRT). METHODS AND RESULTS: Functional measures of baseline frailty and clinical data were collected for all patients with non-ischaemic cardiomyopathy before CRT defibrillator (CRT-D) implantation. The level of frailty was assessed using the Fried and Walston definition. Cox proportional hazard regression models were used to examine the association between baseline frailty and decompensated heart failure (HF) at the 12 months follow-up. The cohort study consisted of 102 patients with a mean age of 73 ± 4 years, 53% of which were male patients. Twenty-nine patients (28%) were classified as frail before CRT-D implantation. Twenty-seven patients experienced decompensated HF after CRT-D implantation at the 12-month follow-up. In the non-frail group, 12 of 73 patients (16.4%) experienced episodes of decompensated HF. In contrast, 15 of 29 (55.6%) frail patients experienced higher proportions of decompensated HF (P < 0.001). Patients who were frail (hazard ratio 4.55, 95% confidence interval 1.726-12.013) were at increased risk for the decompensated HF (P for trend = 0.002) compared with those who were not frail. CONCLUSION: Frailty is a strong predictor of adverse post-implantation outcome in patients with non-ischaemic cardiomyopathy undergoing CRT-D. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Frailty status impacts the prognosis in older patients with heart disease. However, frailty status impact is unknown in patients with non-ischaemic cardiomyopathy after cardiac resynchronization therapy (CRT). METHODS AND RESULTS: Functional measures of baseline frailty and clinical data were collected for all patients with non-ischaemic cardiomyopathy before CRT defibrillator (CRT-D) implantation. The level of frailty was assessed using the Fried and Walston definition. Cox proportional hazard regression models were used to examine the association between baseline frailty and decompensated heart failure (HF) at the 12 months follow-up. The cohort study consisted of 102 patients with a mean age of 73 ± 4 years, 53% of which were male patients. Twenty-nine patients (28%) were classified as frail before CRT-D implantation. Twenty-seven patients experienced decompensated HF after CRT-D implantation at the 12-month follow-up. In the non-frail group, 12 of 73 patients (16.4%) experienced episodes of decompensated HF. In contrast, 15 of 29 (55.6%) frail patients experienced higher proportions of decompensated HF (P < 0.001). Patients who were frail (hazard ratio 4.55, 95% confidence interval 1.726-12.013) were at increased risk for the decompensated HF (P for trend = 0.002) compared with those who were not frail. CONCLUSION: Frailty is a strong predictor of adverse post-implantation outcome in patients with non-ischaemic cardiomyopathy undergoing CRT-D. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Quin E Denfeld; Kerri Winters-Stone; James O Mudd; Jill M Gelow; Sawsan Kurdi; Christopher S Lee Journal: Int J Cardiol Date: 2017-02-10 Impact factor: 4.164
Authors: Quin E Denfeld; Kerri Winters-Stone; James O Mudd; Shirin O Hiatt; Christopher S Lee Journal: J Cardiovasc Nurs Date: 2018 Jan/Feb Impact factor: 2.083
Authors: Quin E Denfeld; Kerri Winters-Stone; James O Mudd; Shirin O Hiatt; Christopher V Chien; Christopher S Lee Journal: Am J Cardiol Date: 2017-01-25 Impact factor: 2.778
Authors: Francisco J Martín-Sánchez; Michael Christ; Òscar Miró; W Frank Peacock; John J McMurray; Héctor Bueno; Alan S Maisel; Louise Cullen; Martin R Cowie; Salvatore Di Somma; Elke Platz; Josep Masip; Uwe Zeymer; Christiaan Vrints; Susanna Price; Christian Mueller Journal: Int J Cardiol Date: 2016-07-18 Impact factor: 4.164